Truvestments Capital’s Aratana Therapeutics, Inc. PETX Stock Holding History

Truvestments Capital’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,450	Closed	-$7K	–	752
2019 Q2	$7K	Sell	1,450 -5,500	-79%	-$24.7K	﹤0.01%	587
2019 Q1	$25K	Buy	+6,950	New	+$30.1K	0.02%	370
2018 Q3	$41K	Buy	+7,064	New	+$35.3K	0.02%	422

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Truvestments Capital's PETX Position: Q3 2019 in Review

Truvestments Capital sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 1,450 shares — an estimated $7K sold.

Truvestments Capital first reported a position in PETX in Q3 2018 and held it in 3 quarters. The position peaked at $41K in Q3 2018. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Truvestments Capital reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Truvestments Capital sold 1,450 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $7K.
Truvestments Capital first reported a position in Aratana Therapeutics, Inc. in Q3 2018 and held it in 3 quarters.
Truvestments Capital's Aratana Therapeutics, Inc. position peaked at $41K in Q3 2018.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Truvestments Capital's 13F filing for Q3 2019, filed 10 Oct 2019.